Form C - Offering Statement:
SEC Accession No. 0001665160-25-000014
Filing Date
2025-01-08
Accepted
2025-01-08 10:36:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9422
2 offeringmemoformc.pdf EX-99 33432401
  Complete submission text file 0001665160-25-000014.txt   45920533
Mailing Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER, 2ND FLOOR PRINCETON NJ 08540 215-554-3530
Eleison Pharmaceuticals Inc (Filer) CIK: 0001880047 (see all company filings)

EIN.: 454373885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-35374 | Film No.: 25517020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)